Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome
Journal of the American Society of Nephrology | Oct 07, 2019
Journal of the American Society of Nephrology | Oct 07, 2019